Boston Scientific completes $850M+ acquisition of spine company

Spinal Tech

Boston Scientific closed its acquisitioon of Relievant Medsystems, which is behind the Intracept intraosseous nerve ablation system, according to a Nov. 17 news release. 

The deal was first announced in September. Intracept will be added to Boston Scientific's chronic pain portfolio that includes spinal cord stimulation, radiofrequency ablation and an interspinous spacer procedure. Intracept recently earned national coverage from Anthem Blue Cross Blue Shield and Humana

The transaction includes an upfromt cash payment of $850 million and contingent payments based on sales over three years.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers